Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Human papillomavirus type 16 L1 capsid protein is the primary structural component of the HPV-16 virion, which is the most prevalent high-risk HPV type associated with human malignancies [UniProt, 2024]. It self-assembles into 72 pentameric capsomeres to form an icosahedral capsid that protects the viral genome and facilitates binding to host cell heparan sulfate proteoglycans [PubMed, 2023]. As the most immunogenic protein of the virus, it is the central component of prophylactic vaccines such as Gardasil 9 and Cervarix, which utilize recombinant L1-based virus-like particles (VLPs) to elicit high titers of neutralizing antibodies [FDA, 2020]. These antibodies prevent the virus from infecting the basal epithelial cells, thereby blocking the development of HPV-associated cancers, including cervical, oropharyngeal, and anal cancers [StatPearls, 2023]. While highly effective as a preventive measure, L1-targeted interventions do not typically clear established infections or treat existing lesions, necessitating continued screening programs [NCI, 2022].
Induction of neutralizing antibodies against the L1 protein to prevent viral attachment and entry into host epithelial cells [StatPearls, 2023].
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human papillomavirus type 16 L1 capsid protein (HPV-16 L1) (HPV-16 L1).